Escherichia coli 'O' group serological responses and clinical correlations in epidemic HUS patients

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 25, Issue 4, 2002, Pages 249-268

  Kulkarni, Hemant ^a   Goldwater, Paul N ^a   Martin, Anne ^a   Bettelheim, Karl A ^b  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Complications; Escherich a coli; Haemolytic uraemic syndrome; Serology

Indexed keywords

BACTERIUM ANTIBODY; SHIGA TOXIN; VEROTOXIN; O ANTIGEN;

AGGLUTINATION TEST; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLOOD SAMPLING; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; EPIDEMIC; ESCHERICHIA COLI; FECES ANALYSIS; GASTROINTESTINAL DISEASE; HEMOLYTIC UREMIC SYNDROME; HEPATOBILIARY DISEASE; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; PATHOGENICITY; SEROTYPING; WESTERN BLOTTING; AUSTRALIA; BLOOD; CHILD; CLUSTER ANALYSIS; ENTEROBACTER INFECTION; EPIDEMIOLOGY; FECES; GROWTH, DEVELOPMENT AND AGING; INFANT; METABOLISM; MICROBIOLOGY; NONPARAMETRIC TEST; PATHOLOGY; PRESCHOOL CHILD; RETROSPECTIVE STUDY;

AGGLUTINATION TESTS; ANTIBODIES, BACTERIAL; BLOTTING, WESTERN; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; DISEASE OUTBREAKS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; HEMOLYTIC-UREMIC SYNDROME; HUMAN; INFANT; O ANTIGENS; RETROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES; SOUTH AUSTRALIA; STATISTICS, NONPARAMETRIC; HUMANS;

ESCHERICHIA COLI;

EID: 0035989204     PISSN: 01479571     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0147-9571(02)00011-5     Document Type: Article

References (34)

1. Association of verotoxin producing E. coli and verotoxin with hemolytic uremic syndrome
2. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin producing E. coli
3. Escherichia coli O157:H7 and hemolytic uremic syndrome: Importance of early cultures in establishing the etiology
4. Serological identification of Escherichia coli O157:H7 in hemolytic uremic syndrome
5. Serum antibodies to Escherichia coli serotype O157:H7 in patients with hemolytic uremic syndrome
6. Antibodies to O antigens of Escherichia coli in patients associated with an outbreak of foodborne haemolytic uraemic syndrome
7. Escherichia coli O group serology of an haemolytic uraemic syndrome (HUS) epidemic
8. Detection of serum antibodies to the lipopolysaccharide of Escherichia coli O103 in patients with hemolytic-uremic syndrome
9. Serum antibodies to verotoxin producing E. coli (VTEC) strains in patients with hemolytic uremic syndrome
10. Indirect hemagglutination assay for antibodies to E. coli lipopolysaccharides O157, O111 and O26 in patients with hemolytic uremic syndrome
11. Community outbreak of hemolytic uremic syndrome attributable to Escherichia coli O111:NM - South Australia
12. Molecular micro-biological investigation of an outbreak of shiga like toxin caused by dry fermented sausage contaminated with shiga-like toxin producing E. coli
13. Haemolytic-uraemic syndrome outbreak caused by Escherichia coli O111:H: Clinical outcomes
14. New method of serotyping Escherichia coli: Implementation and verification
15. Enzyme linked immunosorbent assays for detecting antibodies to shiga like toxin 1, shiga like toxin 2 and Escherichia coli O157:H7 lipopolysaccharide in human serum
16. High incidence of serum antibodies to Escherichia coli O157 lipopolysaccharide in children with hemolytic uremic syndrome
17. Humoral responses to shiga like toxins and E. coli O157 lipopolysaccharide in hemolytic uremic syndrome patients and healthy subjects
18. Hemolytic uremic syndrome and Verocytotoxin producing E. coli infection in Italy, The HUS Italian Study Group
19. Immune response to non-O157 Verotoxin producing E. coli in patients with hemolytic urenic syndrome
20. Indirect hemagglutination assay for diagnosis of E. coli O157 infection in patients with hemolytic uremic syndrome
21. Serum antibodies to secreted proteins in patients infected with E. coli O157 and other VTEC
22. Sporadic case of hemolytic uremic syndrome associated with verotoxin producing E. coli O2:K1:H7
23. Serological identification of infection by verocytotoxin producing E. coli
24. Serum antibodies to secreted proteins in patients infected with E. coli O157 and other VTEC
25. Escherichia coli O157:H7 and hemolytic uremic syndrome: Importance of early cultures in establishing the etiology
26. Direct detection of Escherichia coli shiga-like toxin genes in primary fecal cultures using polymerase chain reaction
27. An outbreak of hemolytic uremic syndrome due to Escherichia coli O157:H: or was it?
28. Immune response to Escherichia coli O157:H7 in hemolytic uremic syndrome following salmonellosis
29. New perspectives on the role of Escherichia coli O157:H7 and other E. coli serotypes in human disease. Review article
30. Diarrhea in young children with Escherichia coli non-O157 organisms that produce shiga-like toxin
31. Molecular analysis of shiga toxigenic Escherichia coli O111:H-proteins which react with sera from patients with hemolytic-uremic syndrome
32. A biotyping scheme for shiga-like (Vero) toxin producing E. coli O157 and a list of serological cross reactions between O157 and other gram-negative bacteria
33. Strains of Escherichia coli belonging to serogroups O157 and O55 express lipopolysaccharides that are structurally distinct and do not share common epitopes
34. Patients with hemolytic uremic syndrome caused by E. coli O157: Absence of antibodies to Verocytotoxin 1 (VT1) or VT2